Lupin Ltd. NSE: LUPIN | BSE: 500257

Mid-range Performer

Download real time

1919.80 -43.70 (-2.23%)

1.1M

NSE+BSE Volume

NSE 26 Sep, 2025 3:31 PM (IST)

US FDA Approval

Lupin gets US FDA tentative nod for its ANDA for HIV treatment tablets with a market size of $16 bn See details

Lupin Ltd. Earnings/Conference Calls

Lupin Ltd. earnings concalls and investor presentations

Is Lupin Ltd. worth buying?

923 Votes:

Buy 72.81%

Sell 17.44%

Hold 9.75%

RESEARCH REPORTS

Buy SEE REPORTS >

Hold SEE REPORTS >